Evidence map›Paper›PMID 27660507›Full record

ArticleThe European respiratory journal2016

The economic effects of supporting tuberculosis-affected households in Peru.

Tom Wingfield, Marco A Tovar, Doug Huff, Delia Boccia, Rosario Montoya, Eric Ramos, James J Lewis, Robert H Gilman, Carlton A Evans

Open access · bronzeAbstract read
In one paragraph

Article in The European respiratory journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 96 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cash transfers to enhance completion of TB screening among household contacts in rural Tanzania.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Social Protection Interventions for TB-Affected Households: A Scoping Review.The American journal of tropical medicine and hygiene · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Tom WingfieldInnovation for Health and Development (IFHAD), Section of Infectious Diseases and Immunity, Imperial College London, and Wellcome Trust Imperial College Centre for Global Health Research, London, UK tom.wingfield@ifhad.org.
Marco A TovarInnovación Por la Salud y Desarrollo, Asociación Benéfica PRISMA, Lima, Perú.
Doug HuffInnovación Por la Salud y Desarrollo, Asociación Benéfica PRISMA, Lima, Perú.
Delia BocciaInnovación Por la Salud y Desarrollo, Asociación Benéfica PRISMA, Lima, Perú.
Rosario MontoyaInnovación Por la Salud y Desarrollo, Asociación Benéfica PRISMA, Lima, Perú.
Eric RamosIFHAD, Laboratory of Research and Development, Universidad Peruana Cayetano Heredia, Lima, Peru.
James J LewisInnovación Por la Salud y Desarrollo, Asociación Benéfica PRISMA, Lima, Perú.
Robert H GilmanJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Carlton A EvansInnovation for Health and Development (IFHAD), Section of Infectious Diseases and Immunity, Imperial College London, and Wellcome Trust Imperial College Centre for Global Health Research, London, UK.
Prisma · PEUniversidad Peruana Cayetano Heredia · PEJohns Hopkins University · USLondon School of Hygiene & Tropical Medicine · GBNorth Manchester General Hospital · GB

Funding

Medical Research Council MR/K007467/1Wellcome TrustWellcome Trust 105788/Z/14/Z
6 · The paper itself

Abstract

The End TB Strategy mandates that no tuberculosis (TB)-affected households face catastrophic costs due to TB. However, evidence is limited to evaluate socioeconomic support to achieve this change in policy and practice. The objective of the present study was to investigate the economic effects of a TB-specific socioeconomic intervention.The setting was 32 shantytown communities in Peru. The participants were from households of consecutive TB patients throughout TB treatment administered by the national TB programme. The intervention consisted of social support through household visits and community meetings, and economic support through cash transfers conditional upon TB screening in household contacts, adhering to TB treatment/chemoprophylaxis and engaging with social support. Data were collected to assess TB-affected household costs. Patient interviews were conducted at treatment initiation and then monthly for 6 months.From February 2014 to June 2015, 312 households were recruited, of which 135 were randomised to receive the intervention. Cash transfer total value averaged US$173 (3.5% of TB-affected households' average annual income) and mitigated 20% of households' TB-related costs. Households randomised to receive the intervention were less likely to incur catastrophic costs (30% (95% CI 22-38%) versus 42% (95% CI 34-51%)). The mitigation impact was higher among poorer households.The TB-specific socioeconomic intervention reduced catastrophic costs and was accessible to poorer households. Socioeconomic support and mitigating catastrophic costs are integral to the End TB strategy, and our findings inform implementation of these new policies.

Indexed as

Health Care CostsAdolescentAdultChildCommunicable Disease ControlFamily CharacteristicsFemaleHealth PolicyHumansIncomeMaleMass ScreeningMiddle AgedModels, EconomicPeruPoverty

Identifiers

PMID27660507
PMCPMC5091496
OpenAlexW2521092842

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.